VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,010,327 | -31.3% | 259,397 | +1.5% | 0.04% | -28.8% |
| Q2 2023 | $2,926,162 | +50.4% | 255,560 | +1.3% | 0.05% | +44.4% |
| Q1 2023 | $1,945,256 | +28.3% | 252,303 | +1.5% | 0.04% | +24.1% |
| Q4 2022 | $1,516,027 | +3.1% | 248,529 | 0.0% | 0.03% | -9.4% |
| Q3 2022 | $1,471,000 | +0.1% | 248,529 | 0.0% | 0.03% | +3.2% |
| Q2 2022 | $1,469,000 | -22.4% | 248,529 | 0.0% | 0.03% | -8.8% |
| Q1 2022 | $1,894,000 | +181.0% | 248,529 | 0.0% | 0.03% | +209.1% |
| Q4 2021 | $674,000 | +3.1% | 248,529 | 0.0% | 0.01% | -8.3% |
| Q3 2021 | $654,000 | +1.9% | 248,529 | +60.0% | 0.01% | 0.0% |
| Q2 2021 | $642,000 | -12.3% | 155,343 | 0.0% | 0.01% | -20.0% |
| Q1 2021 | $732,000 | -34.1% | 155,343 | 0.0% | 0.02% | -34.8% |
| Q4 2020 | $1,111,000 | -33.0% | 155,343 | 0.0% | 0.02% | -41.0% |
| Q3 2020 | $1,658,000 | -15.4% | 155,343 | 0.0% | 0.04% | -20.4% |
| Q2 2020 | $1,960,000 | +37.9% | 155,343 | 0.0% | 0.05% | +19.5% |
| Q1 2020 | $1,421,000 | -34.4% | 155,343 | 0.0% | 0.04% | -19.6% |
| Q4 2019 | $2,167,000 | -18.9% | 155,343 | 0.0% | 0.05% | -23.9% |
| Q3 2019 | $2,673,000 | -36.8% | 155,343 | 0.0% | 0.07% | -39.6% |
| Q2 2019 | $4,228,000 | +42.2% | 155,343 | 0.0% | 0.11% | +38.8% |
| Q1 2019 | $2,973,000 | +103.6% | 155,343 | 0.0% | 0.08% | +77.8% |
| Q4 2018 | $1,460,000 | -50.3% | 155,343 | 0.0% | 0.04% | -45.1% |
| Q3 2018 | $2,939,000 | -2.7% | 155,343 | +0.5% | 0.08% | -9.9% |
| Q2 2018 | $3,020,000 | +4.5% | 154,571 | +0.5% | 0.09% | +2.2% |
| Q1 2018 | $2,890,000 | +59.7% | 153,799 | +41.1% | 0.09% | +64.8% |
| Q4 2017 | $1,810,000 | -19.4% | 109,034 | 0.0% | 0.05% | -21.7% |
| Q3 2017 | $2,245,000 | +129.8% | 109,034 | 0.0% | 0.07% | +130.0% |
| Q2 2017 | $977,000 | -32.0% | 109,034 | +0.4% | 0.03% | -31.8% |
| Q1 2017 | $1,437,000 | +23.7% | 108,561 | +19.1% | 0.04% | +15.8% |
| Q4 2016 | $1,162,000 | +6.1% | 91,175 | 0.0% | 0.04% | 0.0% |
| Q3 2016 | $1,095,000 | – | 91,175 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
| ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
| SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
| GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
| Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
| Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
| Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
| Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |